The Column
Where Bold Ventures Drive Therapeutic Breakthroughs
San Francisco, United States · Founded 2007
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2007
- Business Model
- B2B
- Website
- thecolumngroup.com
About
The Column Group (TCG) is a San Francisco-based biotech venture capital firm founded in 2007, dedicated to building and funding innovative drug discovery companies from inception through exit. TCG operates an integrated ecosystem of funds — including Platform, Opportunity, TCG Labs-Soleil, and TCG Crossover (TCGX) — each pursuing complementary strategies to support life science companies across every stage of development. Over its two-decade history, TCG has started or invested in 55 companies, generated $4 billion in returns for its partners, and achieved 18 company exits. Portfolio companies include Carmot Therapeutics, Aragon Pharmaceuticals, Revolution Medicines, and Eikon Therapeutics.
Summary
The Column is a Biotech company based in San Francisco, United States, founded in 2007.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/the-column"><img src="https://indexed.vc/api/badge/company/the-column" alt="The Column on Indexed.vc" width="260" height="76" /></a>